Clinical Trials · NCT03981627
A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Adocia
- Enrollment
- 44
- Start date
- Jun 2019
- Locations
- 1 site, Germany
- Primary endpoint
- ΔAUCPG(0-4h)